Chemomab Therapeutics Ltd. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.97 | $56.28 M | -5.86 | 2 | $0 |
 BDRX
|
Biodexa Pharmaceuticals Plc | $0.28 | $222,107 | -0.09 | 21 | $381,000 |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.65 | $29.02 M | -0.46 | 100 | $7.88 M |
 CINGW
|
Cingulate Inc. | $0.07 | $4.47 M | -0.01 | 13 | $0 |
 CLRB
|
Cellectar Biosciences, Inc. | $2.14 | $119.38 M | -1.08 | 20 | $0 |
 CVKD
|
Cadrenal Therapeutics, Inc. Common Stock | $13.70 | $7.53 M | 0 | 4 | $0 |
 ELDN
|
Eledon Pharmaceuticals, Inc. | $2.44 | $107.05 M | -2.26 | 20 | $0 |
 HILS
|
Hillstream BioPharma, Inc. | $0.24 | $4.17 M | -0.34 | 1 | $0 |
 LBPH
|
Longboard Pharmaceuticals, Inc. | $33.37 | $682.34 M | -7.8 | 50 | $0 |
 LEXX
|
Lexaria Bioscience Corp. | $3.05 | $46.84 M | -4.88 | 5 | $226,208 |
 LUMO
|
Lumos Pharma, Inc. | $3.85 | $20.13 M | -0.54 | 33 | $2.05 M |
 MNPR
|
Monopar Therapeutics Inc. | $6.72 | $14.18 M | -1.56 | 9 | $0 |
 NAVB
|
Navidea Biopharmaceuticals, Inc. | $0.00 | $10,008 | 0 | 11 | $65,652 |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 ONCR
|
Oncorus, Inc. | $0.12 | $3.29 M | -0.04 | 64 | $0 |
 QNRX
|
Quoin Pharmaceuticals, Ltd. | $0.49 | $2.73 M | -0.11 | 4 | $0 |
 RNXT
|
RenovoRx, Inc. | $1.06 | $24.43 M | -1.46 | 8 | $0 |
 SABS
|
SAB Biotherapeutics, Inc. | $2.70 | $27.17 M | -0.44 | 57 | $2.24 M |
 SNTI
|
Senti Biosciences, Inc. | $2.26 | $12.84 M | -0.15 | 48 | $2.56 M |
 ZVSA
|
ZyVersa Therapeutics, Inc. | $2.41 | $3.68 M | 0 | 7 | $0 |